Mankind Pharma on Wednesday reported a consolidated net profit of Rs 477 crore for the quarter ended March 31, 2024, which was up by 62.2% versus Rs 294 crore reported by the company in the year-ago period.
The revenue from operations stood at Rs 2,441 crore versus Rs 2,053 crore reported in the year-ago period. It was up by 19% on a YoY basis.
<div data-placement=«Mid Article Thumbnails» data-target_type=«mix» data-mode=«thumbnails-mid» style=«min-height:400px; margin-bottom:12px;» class=«wdt-taboola» id=«taboola-mid-article-thumbnails-110152554»>
The company's board on Wednesday approved raising of funds worth Rs 7,500 crore via issuance of equity shares.
<div data-placement=«Mid Article Thumbnails» data-target_type=«mix» data-mode=«thumbnails-mid» style=«min-height:400px; margin-bottom:12px;» class=«wdt-taboola» id=«taboola-mid-article-thumbnails-110152554»>
More to come....
<div data-placement=«Mid Article Thumbnails» data-target_type=«mix» data-mode=«thumbnails-mid» style=«min-height:400px; margin-bottom:12px;» class=«wdt-taboola» id=«taboola-mid-article-thumbnails-110152554»>
(You can now subscribe to our ETMarkets WhatsApp channel)
Read more on economictimes.indiatimes.com